Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Carcinoma (EC)”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableLooking for participantsNCT06893861
What this trial is testing

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

Who this might be right for
Endometrial Carcinoma (EC)
National Cancer Institute, Naples 3,100
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Study completedNCT02035787
What this trial is testing

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06914297
What this trial is testing

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Who this might be right for
Endometrial Cancer
Fudan University 10
Not applicableStudy completedNCT02834988
What this trial is testing

Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Miami 76
Testing effectiveness (Phase 2)Looking for participantsNCT06925724
What this trial is testing

Ivonescimab in People With Endometrial and Cervical Cancers

Who this might be right for
Endometrial CancerCervical Cancer
Memorial Sloan Kettering Cancer Center 50
Not applicableNot Yet RecruitingNCT07675733
What this trial is testing

Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and Feasibility

Who this might be right for
Endometrial Carcinoma (EC)
Royal Marsden NHS Foundation Trust 30
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06129604
What this trial is testing

Pilot Window of Opportunity Trial (POET)

Who this might be right for
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
University of Oklahoma 10
Not applicableNot Yet RecruitingNCT07374809
What this trial is testing

IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER

Who this might be right for
Endometrial Carcinoma (EC)pMMRDMMR Cancer
European Institute of Oncology 50
Large-scale testing (Phase 3)Looking for participantsNCT03463252
What this trial is testing

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Who this might be right for
Endometrial CancerAtypical Endometrial Hyperplasia
West China Second University Hospital 224
Testing effectiveness (Phase 2)Looking for participantsNCT05669430
What this trial is testing

GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more
GV20 Therapeutics 365
Testing effectiveness (Phase 2)Study completedNCT00507741
What this trial is testing

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

Who this might be right for
Ovarian CancerEndometrial Cancer
Endocyte 49
Testing effectiveness (Phase 2)Looking for participantsNCT07070518
What this trial is testing

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more
GV20 Therapeutics 350
Testing effectiveness (Phase 2)Looking for participantsNCT07377734
What this trial is testing

Intrauterine Injection of Type III Collage in FST of EC/AEH

Who this might be right for
Atypical Endometrial HyperplasiaEndometrial Cancer
Wang Jianliu 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Not applicableUnknownNCT05942170
What this trial is testing

The Combination of Preoperative MRI and SLN in the Surgical Management of CC and EC

Who this might be right for
Sentinel Lymph Node BiopsyMRI
Second Affiliated Hospital of Wenzhou Medical University 67
Not applicableNot Yet RecruitingNCT07006103
What this trial is testing

Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification

Who this might be right for
Endometrial Cancer, Endometrial Neoplasm
Hospital Italiano de Buenos Aires 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT03835819
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Who this might be right for
Endometrial Cancer
Dana-Farber Cancer Institute 18
Next Page